Serving hundreds of leading biopharmaceutical companies globally:

Covington
Moodys
Colorcon
Chinese Patent Office
Deloitte
Fish and Richardson
Federal Trade Commission
UBS
Baxter

DrugPatentWatch Media Resources

Contact:
thinkBiotech LLC
1133 15th Street NW, 12th Floor
Washington, DC 20005
adminmail@drugpatentwatch.com@drugpatentwatch.com
202-780-9367

About DrugPatentWatch:
DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs and the 1.3 million global patents and applications covering them.

DrugPatentWatch was founded in 2002, and has served large and small companies throughout the biopharmaceutical value chain. The platform has also been cited by CNN, NEJM, Nature Journals, and many other leading publications.

About Yali Friedman:
Yali Friedman, Ph.D., is founder of thinkBiotech and publisher of the Journal of Commercial Biotechnology. His first book, Building Biotechnology, has been used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. Scientific American also named Dr. Friedman as one of the 100 most influential people in biotechnology.

Dr. Friedman has strong exposure to leading issues in international biotechnology. He is editor of the Scientific American worldVIEW global biotechnology scorecard, a global biotechnology perspective profiling biotechnology industries and innovation capacity in more than fifty countries, and has been invited to participate in biotechnology industry development forums for US federal agencies, international groups such as APEC and ASEAN, and for individual countries such as Canada, Germany, India, Japan, the Philippines, and Turkey.

Dr. Friedman taught biotechnology management at the National Institutes of Health for several years and continues to regularly guest-lecture for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.

Dr. Friedman has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times web property which was named to Forbes "Best of the Web" list. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence platform based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.

Images:

Full Size

Clients in 65 Countries

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.